Consonance Capital Management as of Sept. 30, 2019
Portfolio Holdings for Consonance Capital Management
Consonance Capital Management holds 30 positions in its portfolio as reported in the September 2019 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amarin Corporation (AMRN) | 9.6 | $97M | 6.4M | 15.16 | |
| Catalyst Pharmaceutical Partners (CPRX) | 9.4 | $95M | 18M | 5.31 | |
| United Therapeutics Corporation (UTHR) | 7.6 | $77M | 968k | 79.75 | |
| Globus Med Inc cl a (GMED) | 6.6 | $67M | 1.3M | 51.12 | |
| Tandem Diabetes Care (TNDM) | 6.0 | $60M | 1.0M | 58.98 | |
| Karyopharm Therapeutics (KPTI) | 5.6 | $56M | 5.8M | 9.62 | |
| Uniqure Nv (QURE) | 5.6 | $56M | 1.4M | 39.36 | |
| Vericel (VCEL) | 5.5 | $55M | 3.6M | 15.14 | |
| Align Technology (ALGN) | 5.3 | $54M | 299k | 180.92 | |
| Omeros Corporation (OMER) | 4.6 | $46M | 2.8M | 16.33 | |
| Epizyme | 4.1 | $41M | 4.0M | 10.32 | |
| Oxford Immunotec Global | 3.5 | $36M | 2.1M | 16.63 | |
| STAAR Surgical Company (STAA) | 3.1 | $32M | 1.2M | 25.78 | |
| Iovance Biotherapeutics (IOVA) | 3.0 | $31M | 1.7M | 18.20 | |
| ArQule | 2.9 | $29M | 4.0M | 7.17 | |
| Kadmon Hldgs | 2.7 | $27M | 11M | 2.52 | |
| Retrophin | 2.6 | $27M | 2.3M | 11.59 | |
| Insulet Corporation (PODD) | 2.5 | $26M | 156k | 164.93 | |
| Adma Biologics (ADMA) | 2.2 | $23M | 5.1M | 4.45 | |
| Caredx (CDNA) | 1.6 | $16M | 726k | 22.61 | |
| Aurinia Pharmaceuticals (AUPH) | 1.4 | $14M | 2.6M | 5.34 | |
| Chemocentryx | 1.1 | $11M | 1.7M | 6.78 | |
| Biosante Pharmaceuticals (ANIP) | 1.0 | $10M | 143k | 72.88 | |
| Mustang Bio | 1.0 | $10M | 3.2M | 3.26 | |
| Krystal Biotech (KRYS) | 0.8 | $7.8M | 224k | 34.73 | |
| Savara (SVRA) | 0.4 | $4.2M | 1.6M | 2.65 | |
| Sarepta Therapeutics (SRPT) | 0.1 | $904k | 12k | 75.33 | |
| Homology Medicines | 0.1 | $734k | 41k | 18.10 | |
| Immunomedics | 0.1 | $597k | 45k | 13.27 | |
| Intra Cellular Therapies (ITCI) | 0.0 | $149k | 20k | 7.45 |
